Success Stories: Transformative Biostatistics Research Leads to NIW Approval with NAILG’s Strategic Support
Client’s Testimonial:
“I really appreciate all the help I have received from the Chen Immigration team. From the start, they have been very responsive, all of our communication is through their specialized portal, and is organized in a way that makes the back-and-forth preparation process very efficient. I enjoy the fact that whenever I have a small, random question, I can reach out to the team via message without an appointment. The preparation materials are thorough and really helped me find my strengths to showcase. I would highly recommend working with them for applying for a green card.”
On February 27th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Associate in the Field of Biostatistics (Approval Notice).
General Field: Biostatistics
Position at the Time of Case Filing: Research Associate
Country of Origin: China
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: February 27th, 2025
Processing Time: 5 months, 1 day (Premium Processing Requested)
Case Summary:
Our client has established herself as a highly capable expert in biostatistics, contributing to the advancement of methodologies that improve the quality of clinical data interpretation. Her proposed endeavor focuses on refining statistical methods for both experimental and observational studies, enhancing the reliability of healthcare research in varied disease contexts. This work plays a crucial role in ensuring that real-world evidence is evaluated with scientific rigor, especially important in a time when healthcare analytics increasingly depend on large-scale, observational datasets.
Her innovations directly contribute to:
- Ensure American patients benefit from healthcare informed by robust data
- Bolster the credibility of therapeutic interventions developed from real-world datasets
- Provide the U.S. healthcare system with tools to make more accurate public health and policy decisions
Through this work, she helps guarantee that American patients benefit from therapeutic strategies rooted in dependable data, regardless of the underlying study design. Her methodologies also empower healthcare researchers with tools to derive meaningful insights, thereby elevating the standard of health outcomes and data-driven public policy nationwide.
Her research excellence is demonstrated by:
- 13 peer-reviewed journal articles, including 3 first-authored works, 11 conference abstracts
- 409 citations
- Funding support from the U.S. Food and Drug Administration, the National Heart, Lung, and Blood Institute, the Commonwealth Fund, the Peterson Center on Healthcare, the Blue Cross Blue Shield of Massachusetts Foundation, and the Phyllis and Jerome Lyle Rappaport Foundation
Her contributions have been praised by field leaders. As one recommender wrote:
“Collectively, these contributions represent [Client]’s work is crucial to the development of advanced statistical methodologies for improving the reliability of observational studies and randomized controlled trials, finding applications in answering social and biomedical research questions.”
NAILG’s Strategic Role
The North America Immigration Law Group (NAILG) played a key role in preparing and securing our client’s EB-2 NIW petition. By aligning the petition with her strongest achievements and clearly articulating the national interest served by her work, NAILG ensured that her qualifications were presented with maximum impact. The resulting approval validates the client’s readiness to expand her contributions to U.S. healthcare, applying her statistical expertise to solve pressing challenges in medical research and public health.